U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 11 - 20 of 84

Opioid Stewardship Hub

The resources on this webpage include ideas, insights, and resources to inspire opioid stewardship, and illustrate how hospitals and health systems are working to “Stem the Tide” of the opioid epidemic.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Hospital Association (AHA)
Year
Resource Type
Web Page

The Legal Landscape for Opioid Treatment Agreements

This article surveyed laws and regulations in all 50 states and the District of Columbia, as well as criminal and civil judicial decisions in which opioid treatment agreements were discussed as evidence, finding minimal evidence that they effectively reduce opioid misuse or improve patient outcomes.
Format
Report/Paper/Issue Brief
Audience
Policymakers and Payers
States
Source
The Milbank Quarterly
Year
Resource Type
Article

988 Partner Toolkit

This web page is a resource center for social media, video, print, radio, FAQs, messaging, and other marketing materials that can be used to promote the 988 Suicide & Crisis Lifeline. It is designed for states, territories, tribes, crisis centers, communities, emergency service providers, and other partners to speak with one voice.
Format
Toolkit
Audience
States
Communities
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

Advisory: Prescription Stimulant Misuse and Prevention Among Youth and Young Adults

This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.
Format
Advisory
Audience
Medical Providers
Behavioral Health Providers
Families
Communities
Schools
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
3.6 MB

Alcohol, Tobacco, and Other Drugs

This website provides data and additional resources about the misuse of alcohol, tobacco, and other drugs in the United States, including data from the 2021 National Survey on Drug Use and Health (NSDUH).

Format
Web Page
Audience
Behavioral Health Providers
Medical Providers
Patients
Families
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

Commonly Used Drugs Charts

This NIDA web page includes information on commonly used drugs, including prescription drugs, with the potential for misuse or addiction.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Community Safety Topic - Opioids

This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.

Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
First Responders
Source
National Safety Council (NSC)
Year
Resource Type
Web Page

Medications to Treat Opioid Use Disorder

This fact sheet includes basic descriptions of medications for opioid use disorders (MOUD) including naltrexone, buprenorphine, and methadone. It also addresses how MOUD can help those struggling with opioid use disorder, misunderstandings about MOUD, and additional considerations.
Format
Fact Sheet/Brochure
Audience
Patients
Families
Medical Providers
Other Team Members
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

Mitigating Risks from Human Xylazine Exposure

This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.
Format
Webinar/Video
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Communities
Policymakers and Payers
States
Source
Regan-Udall Foundation for the FDA
Year
Resource Type
Web Page